Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary objective: - To evaluate the efficacy of pasireotide LAR in patients with acromegaly who are inadequately controlled with maximal approved doses of currently available somatostatin analogues Supporting Analysis for Primary objective: - To assess the proportion of patients achieving GH <1µg/L and IGF-1 <ULN by GH level.
Critère d'inclusion
- Acromegaly